Next-generation sequencing of homologous recombination genes could predict efficacy of platinum-based chemotherapy in non-small cell lung cancer

BACKGROUND: With the widespread use of next-generation sequencing (NGS) in clinical practice, an increasing number of biomarkers that predict a response to anti-tumor therapy in non-small cell lung cancer (NSCLC) has been identified. However, validated biomarkers that can be used to detect a respons...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Linlin, Guan, Shasha, Meng, Fanlu, Teng, Lin, Zhong, Diansheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794762/
https://www.ncbi.nlm.nih.gov/pubmed/36591485
http://dx.doi.org/10.3389/fonc.2022.1035808

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794762/
https://www.ncbi.nlm.nih.gov/pubmed/36591485
http://dx.doi.org/10.3389/fonc.2022.1035808

Ejemplares similares